The global multiple myeloma therapeutics market is witnessing sustained growth as healthcare providers, pharmaceutical companies, and research organizations intensify efforts to improve treatment outcomes for patients diagnosed with plasma cell malignancies. According to recent market analysis, the global multiple myeloma therapeutics market was valued at USD 29.49 billion in 2025 and is...